SURECAN
Research type
Research Study
Full title
SUrvivors Rehabilitation Evaluation after CANcer
IRAS ID
168246
Contact name
Peter White
Contact email
Sponsor organisation
Joint Research Management Office
Clinicaltrials.gov Identifier
RP-DG-1212-10014 , Programme Development Grant, code number
Duration of Study in the UK
0 years, 11 months, 31 days
Research summary
We will invite patients attending breast, colorectal, haematological and head and neck cancer clinics, who have finished active cancer treatment, to take part in a qualitative interview to learn which measure of four existing and established quality of life measures are both easiest to use and capture all the important aspects of quality of life. This will then inform our choice of measure as both a screening instrument to assess poor quality of life and a primary outcome measure in a future trial of treatments aimed at improving quality of life in those living beyond cancer. This study is called SURECAN – Survival Rehabilitation Evaluation after CANcer. Ten patients per cancer group with a range of treatment experience will be selected. We will include patients who have had surgery, radiotherapy, chemotherapy and for women with breast cancer in addition biological and endocrine therapy or a combination of these. We will also include patients with different demographic backgrounds; age, gender, ethnicity, and socioeconomic background. Participants will also be asked to describe their experience of surviving cancer in their own words and issues will then be explored. They will then be asked to complete four different quality of life questionnaires and will then be asked specific questions regarding these. They will be asked about their ease of use, appropriateness and whether they cover all areas that participants perceive to be relevant.
REC name
East of England - Cambridgeshire and Hertfordshire Research Ethics Committee
REC reference
15/EE/0198
Date of REC Opinion
21 May 2015
REC opinion
Favourable Opinion